No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.8x · 10Y median 36.5x · 2nd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 27
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:52:35.182Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Nano-X Imaging Ltd. (NNOX) stock was $0.63 as of Oct 6, 2026, 1:48 PM EDT, down 2.60% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -83.5% · 3-year avg -54.5%/yr · 5-year avg -51.3%/yr
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode.
Medical - Devices · Petah Tikva
Next Earnings Date
Nov 19, 2026
44 days away
EPS Estimate
-0.15
Revenue Est.
$5.34M
Last Quarter Results
EPS
$-0.17
vs Estimate
$-0.12
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NNOX | $43.59M | $0.63 | -2.60% | -83.50% | -51.28% | N/A | N/A |
| 2SNWV | $43.55M | $5.07 | +7.77% | -87.32% | -36.36% | -22.68% | vs NNOX |
| 3BSEM | $43.73M | $2.58 | -6.53% | -44.20% | +15.72% | -12.08% | vs NNOX |
| 4RPID | $44.19M | $0.97 | -0.14% | -74.07% | -44.09% | N/A | vs NNOX |
| 5CVRX | $44.58M | $1.68 | +7.69% | -81.94% | -37.86% | N/A | vs NNOX |
| 6HOWL | $45.20M | $0.93 | +0.02% | -54.46% | -44.27% | N/A | vs NNOX |
forward FY estimate
N/A
$4.16M
vs Estimate
$5.38M
Consensus Rating
Based on 3 analysts
Average Price Target
$4.13
+560.0% upside
Low
$3.00
Current
$0.63
High
$5.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.15 | $-0.15 | $-0.15 | 1 |
| Quarter ending Dec 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Quarter ending Mar 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Quarter ending Jun 2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.32 | $-1.26 | $-1.20 | 1 |
| FY 2027 | $-0.54 | $-0.45 | $-0.35 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $4.48M | $5.34M | $6.19M | 2 |
| Quarter ending Dec 2026 | $5.98M | $5.98M | $5.98M | 1 |
| Quarter ending Mar 2027 | $7.74M | $7.74M | $7.74M | 1 |
| Quarter ending Jun 2027 | $7.30M | $7.30M | $7.30M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $18.17M | $19.76M | $21.34M | 1 |
| FY 2027 | $31.16M | $31.97M | $32.78M | 2 |
